| 1. | | Recruiting | Study of S-3304 in Patients with Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer; Lung Cancer; Stage IIIA non small cell lung cancer; Stage IIIB non small cell lung cancer |
| 2. | | Recruiting | Erlotinib in Treating Patients with Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 3. | | Recruiting | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 4. | | Recruiting | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer with Simultaneous Radiotherapy
Conditions: Carcinoma, Non-Small Cell Lung; Lung Cancer |
| 5. | | Not yet recruiting | Anti-angiogenesis Agent AG-013736 in Patients with Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma; Metastases |
| 6. | | Recruiting | ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung |
| 7. | | Recruiting | Avastin/Placebo + Tarceva or Taxotere for Second-line Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Adenocarcinoma; Carcinoma, Large Cell |
| 8. | | Recruiting | A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 9. | | Recruiting | Study of Neurologic Progression with Motexafin Gadolinium and Radiation Therapy (SMART)
Conditions: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm |
| 10. | | Recruiting | Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 11. | | Recruiting | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 12. | | Recruiting | Non-small cell lung cancer refractory to platinum-based therapy
Condition: Carcinoma, Non-Small-Cell Lung |
| 13. | | Recruiting | Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Cancer |
| 14. | | Recruiting | Study of an Oral Tyrosine Kinase Inhibitor of VEGFR-2 for the Treatment of Advanced Stage Non-small Cell Lung Cancer
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 15. | | Recruiting | Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer
Condition: Carcinoma, Non-Small-Cell Lung |
| 16. | | Recruiting | Study to Evaluate AMG 706 with or without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung |
| 17. | | Recruiting | EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 18. | | Recruiting | BAY 43-9006 in Treating Patients With Refractory Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 19. | | Recruiting | Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; ... |
| 20. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 21. | | Recruiting | Study of ILX651 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma
Condition: Non-Small-Cell Lung Carcinoma |
| 22. | | Recruiting | Erlotinib vs. Standard Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer and an Eastern Cooperative Oncology Group Performance Status of 2
Condition: Non-Small Cell Lung Carcinoma |
| 23. | | Recruiting | FDG-PET to Investigate SGN-15 and Docetaxel in Patients with Advanced Non-Small Cell Lung Carcinoma
Condition: Non-Small Cell Lung Carcinoma |
| 24. | | Recruiting | ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 25. | | Recruiting | Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 26. | | Recruiting | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 27. | | Recruiting | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 28. | | Recruiting | Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 29. | | Recruiting | Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
Conditions: Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 30. | | Recruiting | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 31. | | Recruiting | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 32. | | Recruiting | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; ... |
| 33. | | Recruiting | Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 34. | | Recruiting | Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 35. | | Recruiting | ZD6474 Compared With Gefitinib in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 36. | | Recruiting | Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
| 37. | | Recruiting | Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 38. | | Recruiting | Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Anemia; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 39. | | Recruiting | Monoclonal Antibody ABX-EGF as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 40. | | Recruiting | Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 41. | | Recruiting | ABT-751 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That is Refractory to Taxane Therapy
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 42. | | Recruiting | Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 43. | | Not yet recruiting | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 44. | | Recruiting | Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 45. | | Recruiting | High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 46. | | Not yet recruiting | Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 47. | | Recruiting | Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Quality of Life |
| 48. | | Not yet recruiting | Erlotinib in Treating Patients With Early-Stage Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 49. | | Recruiting | Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; ... |
| 50. | | Recruiting | Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
